Showing 17,821 - 17,840 results of 105,667 for search '(( 5 ((ng decrease) OR (a decrease)) ) OR ( 50 ((mean decrease) OR (we decrease)) ))', query time: 1.70s Refine Results
  1. 17821

    Immunofluorescence staining patterns for 5-mC and 5-hmC in CIN3 lesions with overlying columnar epithelium, showing extensive heterogeneity for methylation and hydroxymethylation. by Jobran M. Moshi (18405149)

    Published 2024
    “…In <b>C</b> and <b>E</b> +: indicates areas with an increased 5-hmC immunostaining as compared to * indicating areas with a decrease of 5-hmC immunostaining.…”
  2. 17822
  3. 17823
  4. 17824
  5. 17825
  6. 17826
  7. 17827

    Acute Podocyte Vascular Endothelial Growth Factor (VEGF-A) Knockdown Disrupts alpha<sub>V</sub>beta<sub>3</sub> Integrin Signaling in the Glomerulus by Delma Veron (151378)

    Published 2012
    “…Collectively, these studies indicate that podocyte VEGF-A regulates alpha<sub>V</sub>beta<sub>3</sub> integrin signaling in the glomerulus, and that podocyte VEGF knockdown disrupts alpha<sub>V</sub>beta<sub>3</sub> integrin activity via decreased VEGFR2 signaling, thereby damaging the three layers of the glomerular filtration barrier, causing proteinuria and acute renal failure.…”
  8. 17828

    Targeting of Alpha-V Integrins Reduces Malignancy of Bladder Carcinoma by Geertje van der Horst (458926)

    Published 2014
    “…<div><p>Low survival rates of metastatic cancers emphasize the need for a drug that can prevent and/or treat metastatic cancer. αv integrins are involved in essential processes for tumor growth and metastasis and targeting of αv integrins has been shown to decrease angiogenesis, tumor growth and metastasis. …”
  9. 17829
  10. 17830

    Emission Spectra of the Dried PS-I Complex Containing Various Concentrations of the Peptide Detergents A<sub>6</sub>K and V<sub>6</sub>D by Patrick Kiley (9702)

    Published 2013
    “…<div><p>(A) A<sub>6</sub>K showed significantly enhanced ability to stabilize PS-I at a concentration of 0.5% (w/v) and showed reduced ability to stabilize PS-I complex at decreasing concentration.…”
  11. 17831
  12. 17832
  13. 17833

    Table_1_Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry.DOCX... by Nili Schamroth Pravda (11411216)

    Published 2022
    “…Our cohort consisted of 49 patients (mean age 77.4 ± 10.5 years, 65.3% female). The indications for TM-ViV were mainly for regurgitant pathology (77.6%). …”
  14. 17834

    Image_3_Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry.JPEG... by Nili Schamroth Pravda (11411216)

    Published 2022
    “…Our cohort consisted of 49 patients (mean age 77.4 ± 10.5 years, 65.3% female). The indications for TM-ViV were mainly for regurgitant pathology (77.6%). …”
  15. 17835

    Table_1_MiR-409-5p as a Regulator of Neurite Growth Is Down Regulated in APP/PS1 Murine Model of Alzheimer’s Disease.pdf by Jing Guo (102972)

    Published 2019
    “…We now report that miR-409-5p impairs neurite outgrowth, decreases neuronal viability, and accelerates the progression of Aβ<sub>1</sub><sub>–</sub><sub>42</sub>-induced pathologies. …”
  16. 17836

    Image_1_Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry.JPEG... by Nili Schamroth Pravda (11411216)

    Published 2022
    “…Our cohort consisted of 49 patients (mean age 77.4 ± 10.5 years, 65.3% female). The indications for TM-ViV were mainly for regurgitant pathology (77.6%). …”
  17. 17837

    Image_2_Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry.JPEG... by Nili Schamroth Pravda (11411216)

    Published 2022
    “…Our cohort consisted of 49 patients (mean age 77.4 ± 10.5 years, 65.3% female). The indications for TM-ViV were mainly for regurgitant pathology (77.6%). …”
  18. 17838
  19. 17839
  20. 17840

    Deletion of <i>Smyd1</i> by <i>Tg-Nkx2</i>.<i>5-cre</i> leads to a delayed embryonic lethal cardiac phenotype. by Tara L. Rasmussen (118770)

    Published 2015
    “…<b>E.</b> Decreased proliferation was observed in the hearts of E10.5 <i>Smyd1</i> Tg-CKO embryos. …”